3 studies found for:    15998902 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Erlotinib and Temsirolimus for Solid Tumors
Condition: Solid Tumors
Interventions: Drug: Erlotinib;   Drug: Temsirolimus
2 Completed A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC)
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: sunitinib and rapamycin (Drug will be held)
3 Not yet recruiting A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas
Condition: Chondrosarcoma
Interventions: Drug: Everolimus 2.5 mg/day;   Drug: Everolimus 10 mg/day

Indicates status has not been verified in more than two years